Bart Barlogie
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 0.02%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
- Bone health and treatments
Papers in
- Hematology 581
- Multiple Myeloma Research and Treatments 547
- Hematopoietic Stem Cell Transplantation 53
- Acute Myeloid Leukemia Research 39
-
- Protein Degradation and Inhibitors 157
- Cancer therapeutics and mechanisms 57
- Co-authors
- John D. Shaughnessy (196 shared papers)Guido Tricot (178 shared papers)John Crowley (129 shared papers)Elias Anaissie (103 shared papers)Joshua Epstein (129 shared papers)Frits van Rhee (193 shared papers)Maurizio Zangari (132 shared papers)Sundar Jagannath (78 shared papers)
- Journals
- Blood (303 papers)Journal of Clinical Oncology (59 papers)British Journal of Haematology (44 papers)Bone Marrow Transplantation (19 papers)Leukemia (15 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Bart Barlogie
674 papers receiving 41.4k citations
Bart Barlogie's Hit Papers
Peers
Comparison fields: 5 of 169
- Hematology 30.7k
- Oncology 18.3k
- Genetics 5.7k
- Molecular Biology 24.5k
- Immunology 4.0k
Countries citing papers authored by Bart Barlogie
This map shows the geographic impact of Bart Barlogie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Barlogie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Barlogie more than expected).
Fields of papers citing papers by Bart Barlogie
This network shows the impact of papers produced by Bart Barlogie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Barlogie. The network helps show where Bart Barlogie may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Barlogie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 704 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antitumor Activity of Thalidomide in Refractory Multiple Myeloma Hit paper breakdown → | 1999 | 1963 |
| 2 | International Staging System for Multiple Myeloma Hit paper breakdown → | 2005 | 1943 |
| 3 | The Role of the Wnt-Signaling Antagonist DKK1 in the Development of Osteolytic Lesions in Multiple Myeloma Hit paper breakdown → | 2003 | 1128 |
| 4 | The molecular classification of multiple myeloma Hit paper breakdown → | 2006 | 783 |
| 5 | Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2016 | 594 |
| 6 | A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma Hit paper breakdown → | 2004 | 569 |
| 7 | Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma Hit paper breakdown → | 2006 | 532 |
| 8 | Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells Hit paper breakdown → | 2002 | 507 |
| 9 | Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents Hit paper breakdown → | 1984 | 500 |
| 10 | 2005 | 486 | |
| 11 | 2004 | 483 | |
| 12 | 2006 | 480 | |
| 13 | 2001 | 417 | |
| 14 | 1996 | 416 | |
| 15 | 1997 | 415 | |
| 16 | 1999 | 368 | |
| 17 | 2001 | 365 | |
| 18 | 2003 | 360 | |
| 19 | 1995 | 359 | |
| 20 | 1993 | 358 |
About Bart Barlogie
Bart Barlogie is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 704 papers that have together received 42.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (547 papers), Protein Degradation and Inhibitors (157 papers), Cancer Treatment and Pharmacology (108 papers), Peptidase Inhibition and Analysis (84 papers), Cancer therapeutics and mechanisms (57 papers), Chronic Lymphocytic Leukemia Research (56 papers), Hematopoietic Stem Cell Transplantation (53 papers) and Acute Myeloid Leukemia Research (39 papers). The work is most often cited by research in Hematology (30.7k citations), Oncology (18.3k citations), Genetics (5.7k citations), Molecular Biology (24.5k citations) and Immunology (4.0k citations). Bart Barlogie has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include John D. Shaughnessy, Guido Tricot, John Crowley, Elias Anaissie, Joshua Epstein, Frits van Rhee, Maurizio Zangari, Sundar Jagannath, Fenghuang Zhan and Nikhil C. Munshi. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Bone Marrow Transplantation and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.